DAA Treatment Attitudes among HIV/HCV Co-infected Persons Who Delay or Refuse HCV Treatment

Barriers and facilitators to HCV treatment during the DAA era for the understudied and high-risk population of HIV/HCV co-infected patients who delay or do not consent to treatment, and interventions for increasing DAA treatment uptake.